Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering

Acta Biomaterialia

Volumn 6, Issue 6, 2010, Pages 2091-2096

  Crapo, Peter M ^a,b   Wang, Yadong ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EXPONENT INC   (United States)

Author keywords

Matrigel; Poly(glycerol sebacate); Porcine small intestinal submucosa; Tissue engineering; Tissue engineering scaffolding materials

Indexed keywords

GLYCEROL; HEART; HISTOLOGY; SCAFFOLDS (BIOLOGY); TISSUE;

MATRIGEL; POLIES (GLYCEROLSEBACATE); POLY(GLYCEROL SEBACATE); PORCINE SMALL INTESTINAL SUBMUCOSA; SCAFFOLDING MATERIALS; SMALL INTESTINAL SUBMUCOSA; TISSUE ENGINEERING SCAFFOLDING; TISSUE ENGINEERING SCAFFOLDING MATERIAL; TISSUES ENGINEERINGS;

PROTEINS;

EOSIN; HEMATOXYLIN; MATRIGEL; POLY(GLYCEROL SEBACATE); POLYMER; TISSUE SCAFFOLD; TROPONIN T; UNCLASSIFIED DRUG; BIOMATERIAL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; HEART; HEART MUSCLE CELL; HISTOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMALL INTESTINE; SUBMUCOSA; SWINE; TISSUE ENGINEERING; ANIMAL; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; EXTRACELLULAR MATRIX; FEASIBILITY STUDY; GEL; INTESTINE MUCOSA; INTESTINE SECRETION; MATERIALS TESTING; METHODOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS; SUS;

ANIMALS; ANIMALS, NEWBORN; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; FEASIBILITY STUDIES; GELS; INTESTINAL MUCOSA; INTESTINAL SECRETIONS; INTESTINE, SMALL; MATERIALS TESTING; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77954898678     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.10.048     Document Type: Article

References (67)

1. American Heart Association. Heart disease and stroke statistics-2008 update. Dallas, TX: American Heart Association; 2008.
2. Heidenreich PA, McClellan M. Trends in treatment and outcomes for acute myocardial infarction: 1975-1995. Am J Med 2001;110:165-74.
3. Parmacek MS, Epstein JA. Pursuing cardiac progenitors: regeneration redux. Cell 2005;120:295-8.
4. Von Harsdorf R, Poole-Wilson PA, Dietz R. Regenerative capacity of the myocardium: implications for treatment of heart failure. Lancet 2004;363:1306-13.
5. Baumgartner WA, Burrows S, del Nido PJ, Gardner TJ, Goldberg S, Gorman RC, et al. Recommendations of the National Heart, Lung, and Blood Institute Working Group on Future Direction in Cardiac Surgery. Circulation 2005;111:3007-13.
6. Frigerio M, Roubina E. Drugs for left ventricular remodeling in heart failure. Am J Cardiol 2005;96:10L-8L.
7. Ohtsuka M, Takano H, Zou Y, Toko H, Akazawa H, Qin Y, et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 2004;18:851-3.
8. Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F, et al. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002;105:1548-50.
9. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008;117:1388-96.
10. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 2004;10:403-9.
11. Drexler H, Meyer GP, Wollert KC. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial. Nat Clin Pract Cardiovasc Med 2006;3: S65-8.
12. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel Jr HC, Kormos R, et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005;130:1631-8.
13. Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 2005;112: I173-7.
14. Chachques JC, Trainini JC, Lago N, Masoli OH, Barisani JL, Cortes-Morichetti M, et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant 2008;16:927-34.
15. Yildirim Y, Naito H, Didié M, Karikkineth BC, Biermann D, Eschenhagen T, et al. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 2007;116: I16-23.
16. Shimizu T, Sekine H, Yang J, Isoi Y, Yamato M, Kikuchi A, et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J 2006;20:708-10.
17. Kochupura PV, Azeloglu EU, Kelly DJ, Doronin SV, Badylak SF, Krukenkamp IB, et al. Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 2005;112: I144-9.
18. Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT. Custom design of the cardiac microenvironment with biomaterials. Circ Res 2005;97:8-15.
19. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
20. Bel A, Messas E, Agbulut O, Richard P, Samuel JL, Bruneval P, et al. Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 2003;108(Suppl. 1): II247-52.
21. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 2002;34:107-16.
22. Miyagawa S, Sawa Y, Sakakida S, Taketani S, Kondoh H, Memon IA, et al. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation 2005;80:1586-95.
23. Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R, et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA 2004;101:18129-34. (Pubitemid 40054085)
24. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium. Circulation 2000;102: III56-61.
25. Kutschka I, Chen IY, Kofidis T, Arai T, von Degenfeld G, Sheikh AY, et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 2006;114: I167-73.
26. Baar K, Birla R, Boluyt MO, Borschel GH, Arruda EM, Dennis RG. Selforganization of rat cardiac cells into contractile 3-D cardiac tissue. FASEB J 2005;19:275-7.
27. Furuta A, Miyoshi S, Itabashi Y, Shimizu T, Kira S, Hayakawa K, et al. Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart in vivo. Circ Res 2006;98:705-12.
28. Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S, et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000;17:587-91. (Pubitemid 30256271)
29. Badylak SF, Kochupura PV, Cohen IS, Doronin SV, Saltman AE, Gilbert TW, et al. The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant 2006;15: S29-40.
30. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 1992;202:1-8.
31. Hurst RE, Bonner RB. Mapping of the distribution of significant proteins and proteoglycans in small intestinal submucosa by fluorescence microscopy. J Biomater Sci Polym Ed 2001;12:1267-79.
32. Orkin RW, Gehron P, McGoodwin EB, Martin GR, Valentine T, Swarm R. A murine tumor producing a matrix of basement membrane. J Exp Med 1977;145:204-20.
33. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999;5:662-8.
34. Grant DS, Kibbey MC, Kinsella JL, Cid MC, Kleinman HK. The role of basement membrane in angiogenesis and tumor growth. Pathol Res Pract 1994;190:854-63.
35. Bonfil RD, Vinyals A, Bustuoabad OD, Llorens A, Benavides FJ, Gonzalez-Garrigues M, et al. Stimulation of angiogenesis as an explanation of Matrigelenhanced tumorigenicity. Int J Cancer 1994;58:233-9.
36. Fridman R, Kibbey MC, Royce LS, Zain M, Sweeney M, Jicha DL, et al. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel. J Natl Cancer Inst 1991;83:769-74.
37. Hurst RE, Kyker KD, Bonner RB, Bowditch RD, Hemstreet GP. Matrixdependent plasticity of the malignant phenotype of bladder cancer cells. Anticancer Res 2003;23:3119-28.
38. Parmacek MS, Solaro RJ. Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis 2004;47:159-76.
39. Tan MY, Zhi W, Wei RQ, Huang YC, Zhou KP, Tan B, et al. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 2009;30:3234-40.
40. Radisic M, Park H, Martens TP, Salazar-Lazaro JE, Geng W, Wang Y, et al. Pretreatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res A 2008;86:713-24.
41. Radisic M, Park H, Chen F, Salazar-Lazzaro JE, Wang Y, Dennis R, et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng 2006;12:2077-91.
42. Wang Y, Ameer GA, Shappard BJ, Langer R. A tough biodegradable elastomer. Nat Biotechnol 2002;20:602-6.
43. Chen QZ, Bismarck A, Hansen U, Junaid S, Tran MQ, Harding SE, et al. Characterisation of a soft elastomer poly (glycerol sebacate) designed to match the mechanical properties of myocardial tissue. Biomaterials 2008;29:47-57.
44. Crapo PM, Gao J, Wang Y. Seamless tubular poly (glycerol sebacate) scaffolds: high-yield fabrication and potential applications. J Biomed Mater Res A 2008;86:354-63.
45. Bettinger CJ, Weinberg EJ, Kulig KM, Vacanti JP, Wang Y, Borenstein JT, et al. Three-dimensional microfluidic tissue-engineering scaffolds using a flexible biodegradable polymer. Adv Mater 2006;18:165-9.
46. Gao J, Ensley AE, Nerem RM, Wang Y. Poly (glycerol sebacate) supports the proliferation and phenotypic protein expression of primary baboon vascular cells. J Biomed Mater Res A 2007;83:1070-5.
47. Sundback CA, Shyu JY, Wang Y, Faquin WC, Langer RS, Vacanti JP, et al. Biocompatibility analysis of poly (glycerol sebacate) as a nerve guide material. Biomaterials 2005;26:5454-64.
48. Wang Y, Kim YM, Langer R. In vivo degradation characteristics of poly (glycerol sebacate). J Biomed Mater Res A 2002;66:192-7.
49. Rashid ST, Salacinski HJ, Hamilton G, Seifalian AM. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials 2004;25:1627-37.
50. Gao J, Crapo PM, Wang Y. Macroporous elastomeric scaffolds with extensive micropores for soft tissue engineering. Tissue Eng 2006;12:917-25.
51. Mandarim-de-Lacerda CA, Pereira LM. Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition. Pathobiology 2000;68:36-42.
52. Zhao YS, Wang CY, Li DX, Zhang XZ, Qiao Y, Guo XM, et al. Construction of a unidirectionally beating 3-dimensional cardiac muscle construct. J Heart Lung Transplant 2005;24:1091-7.
53. Okamura S, Suzuki A, Johkura K, Ogiwara N, Harigaya M, Yokouchi T, et al. Formation of the biopulsatile vascular pump by cardiomyocyte transplants circumvallating the abdominal aorta. Tissue Eng 2002;8:201-11.
54. Zimmermann WH, Melnychenko I, Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 2004;25:1639-47.
55. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12:452-8.
56. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough. Circulation 2003;108:1395-403.
57. Kleinman HK, Martin GR. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 2005;15:378-86.
58. Brown B, Lindberg K, Reing J, Stolz DB, Badylak SF. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng 2006;12:519-26.
59. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 2000;68:106-14.
60. Kofidis T, de Bruin JL, Hoyt G, Lebl DR, Tanaka M, Yamane T, et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 2004;128:571-8.
61. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, et al. Perfusiondecellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-21.
62. Badylak S, Obermiller J, Geddes L, Matheny R. Extracellular matrix for myocardial repair. Heart Surg Forum 2003;6: E20-6.
63. Kubin T, Tomars M, Fach C, Hein S, Bramlage P, Shim GJ, et al. Transforming growth factor-beta1 downregulates beating frequency and remodeling of cultured rat adult cardiomyocytes. Cell Tissue Res 2005;321:57-66.
64. Dispersyn GD, Geuens E, Ver Donck L, Ramaekers FC, Borgers M. Adult rabbit cardiomyocytes undergo hibernation-like dedifferentiation when co-cultured with cardiac fibroblasts. Cardiovasc Res 2001;51:230-40.
65. Cheng M, Park H, Engelmayr GC, Moretti M, Freed LE. Effects of regulatory factors on engineered cardiac tissue in vitro. Tissue Eng 2007;13:2709-19.
66. Radisic M, Yang L, Boublik J, Cohen RJ, Langer R, Freed LE, et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol 2004;286: H507-16.
67. Kofidis T, Lenz A, Boublik J, Akhyari P, Wachsmann B, Mueller-Stahl K, et al. Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials 2003;24:5009-14.